Your browser is not supported.

To view this content, please use one of the following browsers:

  • Microsoft Edge
  • Chrome
  • Safari

Where care and collaboration meet,
to make a difference when it matters most


Asthma inhaler technique & training

Dr Stephanie Korn covers "inhaler technique & training" in this video.

Webinar & Videos

Upcoming Webinar

Introducing ▼REZZAYO® rezafungin, the first once weekly echinocandin....

Introducing REZZAYO® rezafungin, the first once weekly echinocandin....

Introducing REZZAYO® (rezafungin), the first once weekly echinocandin indicated for the treatment of invasive candidiasis in adults. Consideration should be given to official guidance on the appropriate use of antifungal agents.1 With a renowned faculty of Professor Oliver Cornely, Professor Tihana Bicanic and Professor Matteo Bassetti.



1. REZZAYO® (rezafungin). Summary of Product Characteristics. Napp 2024.



19:00-20:00 BST

  • Key challenges in the management of invasive candidiasis​
  • The data from the REZZAYO® clinical trial programme​
  • The potential benefits of REZZAYO® in the ICU, ward and for the outpatient
  • Q&A
Click here to access ▼REZZAYO® (rezafungin) GB prescribing Information Click here to access ▼REZZAYO® (rezafungin) NI prescribing Information Register your spot today SIGN UP

®: FLUTIFORM is the Trademark of Jagotec AG used under licence by Mundipharma.